Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross‐sectional study and review of literature

Abstract

In summary, none of these biomarkers was studied in CKD patients. We advance the hypothesis that in both health and disease, under steady state, serum creatinine can serve as a reliable muscle mass biomarker if appropriate adjustment for full or residual kidney function and dietary meat intake is undertaken.